Advertisement
Research ArticleMinireview

Breast Cancer Resistance Protein (ABCG2) in Clinical Pharmacokinetics and Drug Interactions: Practical Recommendations for Clinical Victim and Perpetrator Drug-Drug Interaction Study Design

Caroline A Lee, Meeghan A O'Connor, Tasha K Ritchie, Aleksandra Galetin, Jack A Cook, Isabelle Ragueneau-Majlessi, Harma Ellens, Bo Feng, Mitchell E Taub, Mary F Paine, Joseph W Polli, Joseph A Ware and Maciej J Zamek-Gliszczynski
Drug Metabolism and Disposition January 13, 2015, dmd.114.062174; DOI: https://doi.org/10.1124/dmd.114.062174

Data Supplement

Files in this Data Supplement:

  • Supplemental Table -

    Supplemental Table 1 - Clinically usable compounds and in vitro to in vivo translation inhibition calculations (I1/IC50 and I2/IC50)

    References

  View article